| 东曜药业股份有限公司, 01875.HK - 公司概览 |
| 集团主席 |
付山 |
| 发行股本(股) |
773,000,000 |
| 面值币种 |
| 股票面值 |
0.0 |
| 行业分类 |
生物技术 |
| 公司业务 |
集团主要在中华人民共和国（「中国」）从事抗肿瘤药物的研究与开发（「研发」）、生产及营销、合约开发生产组织（「CDMO」）╱合约生产组织（「CMO」）业务以及自主开发生物药物的对外许可。 |
资料来源于上市公司财务报表
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window